Approval · Notice of Compliance 9895 · 2008
VOLUVEN: Notice of Compliance 9895
Issued November 13, 2008
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 9895
- Date
- November 13, 2008
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- To remove sodium chloride from the list of active ingredients in the certified product information document and product monograph
- Therapeutic class
- Plasma volume expander
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| VOLUVEN | Not yet assigned | — |
Medicinal ingredients
- HYDROXYETHYL STARCH 6 PER